AsuRock™ is a medicinal cream that treats pododermatitis on dogs, cats, poultry, cattle, sheep and horses. Pododermatitis is a form of digital dermatitis, which has a multi-factorial origin that includes bacterial and fungal infections, as well as allergic reactions to a wide set of allergens.
This new veterinary drug product will effectively treat and cure mild to severe cases of digital dermatitis in about three to four weeks. Any medical treatment that uses AsuRock™ will also save several visits to the veterinary, avoid painful and ineffective treatments like surgery, minimize the weakness of the animal’s immune system through antibiotic’s cocktails, minimize economic losses, and have a positive impact in extending the life and quality of life of pets and farm animals around the World.
PRODUCT FEATURES & BENEFITS
- Treats and cures pododermatitis
- Improves foot and hoof health of large and small animals
- Easy to apply
- Effective medicine with proven results
- Cures all forms of digital dermatological infections
- Works for dogs, cats, poultry, cows, sheep and horses
- Cures dermatitis within three weeks
- Prevents multiple visits to the vet
- Relieves the animal’s stress, pain and discomfort
- Avoids painful and ineffective treatment, such as surgery
- Improves quality of life for the infected animal
AsuROCK™ is a new veterinary drug product that will effectively treat digital dermatitis on dogs, cats, poultry, cattle, sheep, and horses, and could potentially cure digital dermatitis in a time no longer than 3 weeks. It prevents multiple visits to the veterinarian, avoids painful and ineffective treatments like surgery, minimizes the weakness of the animal’s immune system through antibiotic’s cocktails, minimize economic losses, and has a positive impact in extending the life and quality of life of pets and farm animals.
AsuROCK™ was invented to treat Interdigital Furunculosis in dogs, for which no cure is currently on the market. The inefficiency of the various other treatments presented here obeys to the quick adaptation of the microorganisms by becoming resistant to any battery of antibiotics that have been used against them. This new product has overcome such difficulties by exposing the lesion, via one of its ingredients, to proper treatment.
AsuROCK™ contains 15 ingredients that make the final formulation. This novel medicine has been used successfully by Griselle García, also owner of G&G PETCURAE, and tested on her own dogs, English bulldogs, for the last 11 years.
The AsuROCK™ is covered by United States Utility Patent: 10,206,935
For additional information, licensing opportunities, and a full prospectus on the AsuROCK™ contact:
VP of Business Development